TPMS technology to infer biomarkers of macular degeneration prognosis in in silico simulated prototype-patients under the study of heart failure treatment with sacubitril and valsartan
Guillem Jorba, Joaquim Aguirre‐Plans, Valentin Junet, Cristina Segú-Vergés, José Luis Ruiz, Albert Pujol, Narcís Fernández‐Fuentes, José Manuel Mas, Baldomero Oliva
The paper uses TPMS to model drug mechanisms and identify biomarkers linked to macular degeneration as an adverse effect of heart failure treatment with sacubitril/valsartan.
PLoS ONE · Feb 13, 2020Peer-reviewedBioinformatics